Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis.
Jessica Elisabetta EspositoVincenzo De IuliisFrancesco AvolioEliana LiberatoscioliRiccardo PulciniSimona Di FrancescoAlfonso PennelliStefano MartinottiElena ToniatoPublished in: Cancers (2022)
TRIM/RBCC are a large family of proteins that include more than 80 proteins, most of which act as E3 ligases and catalyze the direct transfer of Ubiquitin, SUMO and ISG15 on specific protein substrates. They are involved in oncogenesis processes and in cellular immunity. On this topic, we focus on TRIM8 and its multiple roles in tumor pathologies. TRIM8 inhibits breast cancer proliferation through the regulation of estrogen signaling. TRIM8 downregulation in glioma is involved in cell proliferation, and it is related to patients' survival. Several studies suggested that TRIM8 regulates the p53 suppressor signaling pathway: it is involved in the NF-kB pathway (Nuclear Factor kappa light- chain-enhancer of activated B cells) and in STAT3 (Signal Transducer and Activator of Transcription 3) of the JAK-STAT pathway. In this review, we summarize how the association between these different pathways reflects a dual role of TRIM8 in cancer as an oncogene or a tumor suppressor gene.
Keyphrases
- nuclear factor
- signaling pathway
- cell proliferation
- toll like receptor
- papillary thyroid
- pi k akt
- end stage renal disease
- binding protein
- transcription factor
- chronic kidney disease
- cell cycle
- ejection fraction
- small molecule
- oxidative stress
- squamous cell carcinoma
- protein protein
- amino acid
- childhood cancer
- immune response
- genome wide
- lymph node metastasis
- inflammatory response
- case control